Related Experiment Video
Updated: Dec 6, 2025

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
998
Prevention of suicidal behavior in bipolar disorder
Leonardo Tondo1,2,3, Gustavo H Vázquez2,4, Ross J Baldessarini1,2
1Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Bipolar Disorders
|October 10, 2020
Summary
Individuals with bipolar disorder (BD) face significantly higher suicide risks compared to the general population. Further research is urgently needed to develop effective suicide prevention treatments for BD patients.
Area of Science:
- Psychiatry
- Mental Health Research
- Suicidology
Background:
- Bipolar disorder (BD) is associated with excess mortality, primarily due to comorbid medical conditions and suicide.
- Suicide remains a critical and challenging aspect of managing bipolar disorder.
Purpose of the Study:
- To review the current status of suicide in bipolar disorder.
- To explore possibilities for limiting suicidal risk in BD patients.
Main Methods:
- A semi-systematic review of recent research on suicide in bipolar disorder was conducted.
Main Results:
- Suicide rates in BD are substantially higher (over 200/100,000 annually for adults) than in the general population (11/100,000).
- Key risk factors include prior suicide attempts, depression, mood instability, impulsivity, and substance abuse.
- Current suicide-preventing treatments for BD are underdeveloped, with lithium showing the strongest evidence.
Conclusions:
- Suicide is a primary clinical challenge in bipolar disorder care.
- Enhanced understanding of risk/protective factors and close patient monitoring can mitigate suicidal risk.
- Urgent need for ethically sound research into novel treatments for suicide prevention in BD.
More Related Videos
Related Concept Videos
Mania and Antimanic Drugs: Overview
458
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
458
Bipolar Disorder
457
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
457
Psychosis: Goals of Pharmacotherapy
354
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
354
Electroconvulsive Therapy
482
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
482
Psychosis and Antipsychotic Drugs: Overview
668
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
668
Antidepressant Drugs: MAOIs and Other Agents
646
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
646

